Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study

BACKGROUND: The prognosis of pT1a-pT1b breast cancer (BC) used to be considered very good, with a 10-y RFS of 90%. However, some retrospective studies reported a 10-y RFS of 81%–86% and suggested benefit from adjuvant systemic therapy. METHODS: To evaluate the variables that determined the choice of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gori, Stefania, Clavarezza, Matteo, Siena, Salvatore, Foglietta, Jennifer, Tarenzi, Emiliana, Giordano, Monica, Molino, Annamaria, Graiff, Claudio, Fusco, Vittorio, Alabiso, Oscar, Baldini, Editta, Gamucci, Teresa, Altavilla, Giuseppe, Dondi, Davide, Venturini, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404902/
https://www.ncbi.nlm.nih.gov/pubmed/22545982
http://dx.doi.org/10.1186/1471-2407-12-158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404902/
https://www.ncbi.nlm.nih.gov/pubmed/22545982
http://dx.doi.org/10.1186/1471-2407-12-158

Ejemplares similares